Barrigel

The Future of Prostate Spacing is Here

shutterstock_397400119.jpg
Screen Shot 2020-09-23 at 09.10.16.png

A biodegradable injectable device for protection of the rectal wall when treating prostate cancer with radiation. BARRIGEL is approved for prostate rectum separation in Australia and Europe.

  • BARRIGEL is CE-Marked and indicated for prostate spacing

  • The prostate spacing market first published with Non-Animal Stabilised Hyaluronic Acid (NASHA®) in 2007

  • More than 2,500 RT patients have been treated with NASHA

Barrigel is the Next Generation Spacer

NASHA the Proven Solution

  • BARRIGEL is the first commercially available hyaluronic acid (HA) spacer

  • NASHA has a long history of safety, efficacy and biocompatibility

  • Over 40 million treatments with NASHA

NASHA puts you in Control

  • No polymerisation or hardening, allowing unrestricted time for injection quality assurance

  • Gel viscosity remains uniform and consistent to sculpt the space

  • Uniform distribution for desired sculpted space and volume

Moving to BARRIGEL is an easy Transition

BARRIGEL is packaged for immediate use in a single syringe 7

1. No preparation is required (patient ready, single pre-filled syringe)

2. No shaking is required

3. No waiting is required

4. No time constraints